The first-generation hemoglobin blood substitutes rely on molecular modifications of hemoglobin, either by chemically cross linking the molecules or by modifying them using recombinant DNA technology.
英
美
- 第一代的血红蛋白血液替代品,要么是依靠化学交联法,要么是利用重组DNA技术,对血红蛋白分子进行修改。